Brookdale Senior Living (BKD) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
11 Aug, 2026Executive summary
Achieved 8.2% year-over-year RevPAR growth in Q2 2026, with weighted average occupancy up 230 bps to 82.4% and same community occupancy at 82.9% (+110 bps).
Adjusted EBITDA for Q2 2026 was $122.1M, up 4.3% year-over-year, and net income was $23.3M, reversing a prior year loss.
Portfolio optimization included the sale of up to 16 communities for $150M–$190M, acquisition of Brookdale Galleria for $23.4M, and agreement to acquire 17 leased communities for $157M.
Strategic focus on operating performance, real estate optimization, capital reinvestment, and deleveraging.
Expanded revolving credit facility to $200M and refinanced all 2027 mortgage maturities, eliminating near-term debt maturities until 2028.
Financial highlights
Q2 2026 revenue was $718.6M, down 11.6% year-over-year due to asset dispositions; net income was $23.3M vs. $(43.0)M prior year.
Resident fees were $708M, down 8.7% year-over-year, but same community RevPAR rose 5.5% and RevPOR 4.1%.
Facility operating expenses decreased 10.5% year-over-year, mainly from asset sales.
Adjusted free cash flow was $38.2M for Q2, with expectations to be significantly positive for the year.
Total liquidity at June 30, 2026 was $565.8M, including $370.4M cash and $175.6M credit facility availability.
Outlook and guidance
Reaffirmed 2026 guidance: 8%-9% RevPAR growth and $502M-$516M adjusted EBITDA.
Expect full-year consolidated occupancy of ~83% and anticipate stronger RevPAR and occupancy growth in Q3 and Q4.
Projected annual G&A expense of $157M and cash lease expense slightly under $180M.
Multi-year outlook: mid-teen annual adjusted EBITDA growth and leverage ratio below 6x by end of 2028.
Management expects liquidity and cash flows from operations, plus credit facility access, to be sufficient for at least the next 12 months.
Latest events from Brookdale Senior Living
- Operational restructuring, targeted CapEx, and market-focused M&A drive growth amid strong demand.BKD
Barclays 28th Annual Global Healthcare Conference - Growth-focused strategy, strong pricing, and portfolio optimization drive EBITDA and cash flow gains.BKD
RBC Capital Markets Global Healthcare Conference 2026 - Occupancy and EBITDA are set to rise as strategic changes and strong demand drive growth.BKD
Bank of America Global Healthcare Conference 2026 - Q1 2026 saw strong RevPAR and occupancy gains, improved profitability, and reaffirmed guidance.BKD
Q1 2026 - Director elections, executive pay, and auditor ratification headline the 2026 annual meeting.BKD
Proxy filing - Director elections, executive pay, and auditor ratification headline the annual meeting agenda.BKD
Proxy filing - Record 2025 EBITDA and occupancy growth set the stage for robust 2026 performance.BKD
Q4 2025 - Q2 saw 20% Adjusted EBITDA growth, higher occupancy, but a wider net loss on higher costs.BKD
Q2 2024 - Q1 2025 saw 80% occupancy, asset streamlining, and Health Plus driving growth and retention.BKD
RBC Capital Markets Global Healthcare Conference 2025